Tilbæk S, Elleberg Petersen S, Stolarczyk L, Vestergaard A, Rønde HS, Bentzen LN, et al. Plan robustness evaluation strategies in whole-pelvic proton therapy for high-risk prostate cancer patients within a randomised clinical trial. AO [Internet]. 2023 Nov. 2 [cited 2026 May 24];62(11):1455-60. Available from: https://medicaljournalssweden.se/actaoncologica/article/view/35145